Nasdaq · Healthcare
MeiraGTx Holdings plc (MGTX)
As-reported financials and recent SEC filings for MeiraGTx Holdings plc, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$81.4M
Net income
$-114.2M
Net margin
-140.3%
Diluted EPS
$-1.42
ROE
1971.4%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2021 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $81.4M | $33.3M | $14.0M | $15.9M | $37.7M |
| Gross profit | — | — | — | — | — |
| Operating income | $-106.0M | $-164.2M | $-137.1M | $-116.4M | $-72.8M |
| Net income | $-114.2M | $-147.8M | $-84.0M | $-129.6M | $-79.6M |
| Diluted EPS | $-1.42 | $-2.12 | $-1.49 | $-2.87 | $-1.80 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-29
View on EDGAR →42026-06-29
View on EDGAR →42026-06-29
View on EDGAR →42026-06-29
View on EDGAR →42026-06-29
View on EDGAR →42026-06-15
View on EDGAR →42026-06-15
View on EDGAR →42026-06-15
View on EDGAR →Largest Healthcare peers
Go deeper on MGTX
Search MeiraGTx Holdings plc’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.